Global Perspectives on Melanoma, Squamous Cell Carcinoma (SCC), and Basal Cell Carcinoma (BCC)

June 26, 2021

Faculty Chair

Jeffrey S. Weber, MD, PhD

NYU Langone Medical Center, New York, NY, USA

Faculty Members

Omid Hamid, MD
Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA

Adi Diab, MD
MD Anderson Cancer Center, Houston, TX, USA

Alexander Eggermont, MD, PhD
Princess Máxima, Utrecht, the Netherlands

Ragini Kudchadkar, MD
Emory University, Atlanta, GA, USA

Hussein Tawbi, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA

Sample Report

Start discovering the insights

View Report


  • New perspectives in melanoma adjuvant and neoadjuvant therapy
  • Emerging insights in relapsed/refractory metastatic melanoma
  • Evolution of immunotherapy for 1L metastatic melanoma
  • 1L BRAF-mutated metastatic melanoma –Strategies to improve on MAPK-targeted therapies
  • Emerging advances in the management of BCC

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.